Abstract:Lipids are essential biomolecules in the brain, as they have important roles in signaling and structural integrity. Of note, the central nervous system has a high concentration of lipids, second only to adipose tissue. Recently, it has been shown that abnormalities in lipid levels play a critical role in the onset of neurodegenerative diseases including Alzheimer’s disease (AD). AD is a progressive and severe neurodegenerative disease and the leading cause for dementia, affecting millions worldwide. However, the spatial localization of individual lipid molecules in normal brain tissues, as well as region‐specific lipid alterations during AD are yet to be explored. Additionally, current understanding of potential sexual dimorphisms in lipid localization in brain is incomplete. With these in mind, we employed high‐resolution matrix‐assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) coupled to ion mobility mass spectrometry to characterize region‐specific lipid distribution in brain obtained from age‐ and sex‐matched wild type and AD mice (18‐month‐old female C57BL/6J and 3xTg‐AD mice, which exhibits both amyloid and tau pathology, n=3 per group). Additionally, the spatial distributions of lipids were investigated in male and female mice within two different age groups (4 and 12‐week‐old, n=3 per group). From these experiments, we were able to detect more than one thousand ions in brain tissue sections. Following detection, we annotated an approximate 100 lipid molecules with high confidence. Tissue imaging results revealed region‐specific distributions of specific lipids representing a range of classes including phosphatidylcholines, lysophosphatidylcholines, phosphatidylethanolamines, ceramide phosphates, sphingomyelins, sulfated hexosyl ceramides, and ceramide phosphoinositols across male and female mice. Interestingly, ceramide phosphate (30:7), lysophosphatidylcholine (16:0), and phosphatidylcholine (36:5) molecules exhibited sex‐specific localization patterns restricted to the cerebellum in 4‐week‐old male mice. Further, ceramide phosphoinositol (42:6) was localized to the cerebellum region of 12‐week‐old male and female mice whereas 4‐week‐old male and female mice showed relative homogeneous spatial distribution. Notably, we observed region‐specific alterations in the spatial localization of several lipid molecules including phosphatidylcholine [(40:6), and (40:7)] and sulfated hexosyl ceramide [(16:1;2O/22:2;O), (24:2;2O/12:1;O), and (19:0;2O/15:0;O)] in AD mice as compared to age‐ and sex‐matched controls. These observed changes occurred in the hippocampus region and were further confirmed using receiver operating characteristic analysis. Taken together, the above results reveal highly localized patterns of alterations in lipid molecules across male and female mice, as well as during AD.

Ion mobility-based sterolomics reveals spatially and temporally distinctive sterol lipids in the mouse brain

Spatial Sterol Metabolism Unveiled by Stimulated Raman Imaging

Localization of sterols and oxysterols in mouse brain reveals distinct spatial cholesterol metabolism

Multiplatform lipid analysis of the brain of aging mice by mass spectrometry

Spatially and temporally probing distinctive glycerophospholipid alterations in Alzheimer's disease mouse brain via high-resolution ion mobility-enabled sn-position resolved lipidomics

Revealing Sex and Alzheimer’s Disease‐related Changes in the Spatial Localization of Brain Lipids in Mice using Mass Spectrometry Imaging

Optics-free Spatial Genomics for Mapping Mouse Brain Aging

MALDI mass spectrometry imaging discloses the decline of sulfoglycosphingolipid and glycerophosphoinositol species in the brain regions related to cognition in a mouse model of Alzheimer's disease

Spatially resolved transcriptome of the aging mouse brain

Applying Spatial Metabolomics To Investigate Age- and Drug-Induced Neurochemical Changes

Brain Lipid Dynamics in Amyloid Precursor Protein/Presenilin 1 Mouse Model of Early Alzheimer's Disease by Desorption Electrospray Ionization and Matrix Assisted Laser Desorption Ionization-Mass Spectrometry Imaging Techniques

A metabolome atlas of the aging mouse brain

Spatial transcriptomic brain imaging reveals the effects of immunomodulation therapy on specific regional brain cells in a mouse dementia model

Four-Dimensional Untargeted Profiling of <i>N</i>-Acylethanolamine Lipids in the Mouse Brain Using Ion Mobility-Mass Spectrometry

Molecular and spatial signatures of mouse brain aging at single-cell resolution

Serum Metabolomic Profiling in Aging Mice Using Liquid Chromatography—Mass Spectrometry

Untargeted Lipidomics Reveals Progression of Early Alzheimer’s Disease in APP/PS1 Transgenic Mice

Spatial and single-cell profiling of the metabolome, transcriptome and epigenome of the aging mouse liver

Biosystems Study of the Molecular Networks Underlying Hippocampal Aging Progression and Anti-aging Treatment in Mice.

Mass spectrometry imaging highlights dynamic patterns of lipid co‐expression with Aβ plaques in mouse and human brains

Proteomic Profile of Mouse Brain Aging Contributions to Mitochondrial Dysfunction, DNA Oxidative Damage, Loss of Neurotrophic Factor, and Synaptic and Ribosomal Proteins